Last reviewed · How we verify
Low Metformin
At a glance
| Generic name | Low Metformin |
|---|---|
| Also known as | Metformin, L-Leucince, Leucine, Metformin, Leucine, L-Leucine |
| Sponsor | NuSirt Biopharma |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (PHASE1, PHASE2)
- Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? (NA)
- Safety and Feasibility of Metformin for Sepsis Induced AKI (PHASE2)
- Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho (NA)
- PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes (NA)
- Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes (NA)
- Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low Metformin CI brief — competitive landscape report
- Low Metformin updates RSS · CI watch RSS
- NuSirt Biopharma portfolio CI